A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer
Public ClinicalTrials.gov record NCT03899649. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Registry to Evaluate Effectiveness and Safety of the NanoKnife System for the Ablation of Stage 3 Pancreatic Adenocarcinoma
Study identification
- NCT ID
- NCT03899649
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Angiodynamics, Inc.
- Industry
- Enrollment
- 532 participants
Conditions and interventions
Conditions
Interventions
- SOC Drug
- NanoKnife System Device
Drug · Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 7, 2019
- Primary completion
- Mar 31, 2025
- Completion
- Mar 31, 2025
- Last update posted
- Feb 11, 2025
2019 – 2025
United States locations
- U.S. sites
- 14
- U.S. states
- 12
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Moores Cancer Center, UC San Diego Health | La Jolla | California | 92093 | — |
| University of Florida Health | Gainesville | Florida | 32608 | — |
| Miami Cancer Institute | Miami | Florida | 33176 | — |
| Wellstar Medical Group | Marietta | Georgia | 30060 | — |
| Northwest Community Hospital | Arlington Heights | Illinois | 60005 | — |
| University of Iowa Healthcare | Iowa City | Iowa | 52242 | — |
| Norton Healthcare | Louisville | Kentucky | 40202 | — |
| Mayo Clinic, Rochester | Rochester | Minnesota | 55905 | — |
| Barnes-Jewish Hospital | St Louis | Missouri | 63110 | — |
| NYU Langone | New York | New York | 10016 | — |
| Presbyterian Hospital, Columbia | New York | New York | 10032 | — |
| Atrium Health | Charlotte | North Carolina | 28204 | — |
| St. Luke's University Health Network | Easton | Pennsylvania | 18045 | — |
| University of Texas-Southwestern | Dallas | Texas | 75231 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03899649, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 11, 2025 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03899649 live on ClinicalTrials.gov.